PUBLISHER: Azoth Analytics | PRODUCT CODE: 1375306
PUBLISHER: Azoth Analytics | PRODUCT CODE: 1375306
Azoth Analytics has released a research report titled "Global Branded PAH Therapeutics Market (2023 Edition)" which provides a complete analysis of the Global Branded PAH Therapeutics industry in terms of market segmentation By Drug Class (Endothelin Receptor Antagonist -ERA's, TGF-B Ligand Traps and Soluble guanylate cyclase - sGC stimulators, Prostacyclin Receptor Agonists, Others), By Route of Administration (Oral, Intravenous/Subcutaneous, Others), By Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies), By Region (Americas, Europe, Asia-pacific, Middle-East & Africa), for the historical period of 2019-2022, the estimates of 2023 and the forecast period of 2024-2029.
The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, United Kingdom, Germany, France, Italy, China, Japan, India, South Korea). Additionally, the research report presents data including market size, yearly growth & potential analysis, the competitive study of market players, investment opportunities and demand forecast.
The research report also assesses growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market evolution.
The Global Branded PAH Therapeutics Market is expected to generate USD 9.86 billion by the end of 2029, up from USD 6.67 billion in 2022. A favourable growth element for the global Branded PAH Therapeutics market is propelled by increasing prevalence, advancement in research and development, evolving treatment landscape and regulatory approvals. During the forecast period, 2024-2029, Global Branded PAH Therapeutics is expected to expand at a CAGR of 5.89%. The development of targeted therapies, including prostacyclin analogs, endothelin receptor antagonists, and tyrosine kinase inhibitors, has revolutionized the treatment of PAH. These therapies offer better disease management and outcomes, driving market growth.
Pulmonary hypertension is becoming an increasingly common global health issue, according to The Pulmonary Vascular Research Institute Pulmonary arterial hypertension (PAH), especially the idiopathic form, although still a rare disease with an incidence of 2-5 per million adults, is increasingly being diagnosed in elderly people. A growing understanding of PAH, along with improved diagnostic methods, has led to an increase in the diagnosed cases of PAH worldwide.
Ongoing research efforts to better understand the pathophysiology of PAH and to develop more effective treatments are a significant driver of the market. New drug discoveries and improved therapies drive branded PAH therapeutics growth. The development and approval of novel PAH medications, such as macitentan (Opsumit) and selexipag (Uptravi), are the results of continuous R&D efforts. These drugs have demonstrated improved efficacy and safety profiles.
Retail pharmacies are often widely distributed, making branded PAH medications more accessible to patients, including those in remote or rural areas. Increased accessibility helps ensure that patients have access to essential medications, reducing barriers to treatment. Also, retail pharmacies provide a convenient location for patients to fill initial prescriptions and receive refills of branded PAH therapeutics. This simplifies the medication acquisition process, supporting ongoing treatment.
Innovations in drug delivery systems, such as subcutaneous and implantable infusion pumps, provide more convenient and continuous delivery of prostacyclin analogs, improving patient adherence and reducing the burden of intravenous administration. Advanced delivery systems enhance patient comfort and treatment adherence, leading to better control of PAH symptoms and improved patient outcomes. Technological advancements have transformed the landscape of PAH diagnosis, treatment, and patient care. They have improved the accuracy and efficiency of diagnosis, enabled more personalized therapies, and enhanced the quality of life for PAH patients. Additionally, the integration of technology has the potential to drive further innovation in the field, improving outcomes for individuals living with PAH.
Scope of the Report:
List of Tables
Table A1: Global Impact of Macro Economic Factors, By Region
Table A2: United States AAC Devices Market, By Device Type, 2019-2022 (USD Million)
Table A3: United States AAC Devices Market, By Device Type, 2023-2029 (USD Million)
Table A4: United States AAC Devices Market, By Application, 2019-2022 (USD Million)
Table A5: United States AAC Devices Market, By Application, 2023-2029 (USD Million)
Table A6: United States AAC Devices Market, By End-Users, 2019-2022 (USD Million)
Table A7: United States AAC Devices Market, By End-Users, 2023-2029 (USD Million)
Table A8: Canada AAC Devices Market, By Device Type, 2019-2022 (USD Million)
Table A9: Canada AAC Devices Market, By Device Type, 2023-2029 (USD Million)
Table A10: Canada AAC Devices Market, By Application, 2019-2022 (USD Million)
Table A11: Canada AAC Devices Market, By Application, 2023-2029 (USD Million)
Table A12: Canada AAC Devices Market, By End-Users, 2019-2022 (USD Million)
Table A13: Canada AAC Devices Market, By End-Users, 2023-2029 (USD Million)
Table A14: Mexico AAC Devices Market, By Device Type, 2019-2022 (USD Million)
Table A15: Mexico AAC Devices Market, By Device Type, 2023-2029 (USD Million)
Table A16: Mexico AAC Devices Market, By Application, 2019-2022 (USD Million)
Table A17: Mexico AAC Devices Market, By Application, 2023-2029 (USD Million)
Table A18: Mexico AAC Devices Market, By End-Users, 2019-2022 (USD Million)
Table A19: Mexico AAC Devices Market, By End-Users, 2023-2029 (USD Million)
Table A20: Germany AAC Devices Market, By Device Type, 2019-2022 (USD Million)
Table A21: Germany AAC Devices Market, By Device Type, 2023-2029 (USD Million)
Table A22: Germany AAC Devices Market, By Application, 2019-2022 (USD Million)
Table A23: Germany AAC Devices Market, By Application, 2023-2029 (USD Million)
Table A24: Germany AAC Devices Market, By End-Users, 2019-2022 (USD Million)
Table A25: Germany AAC Devices Market, By End-Users, 2023-2029 (USD Million)
Table A26: United Kingdom AAC Devices Market, By Device Type, 2019-2022 (USD Million)
Table A27: United Kingdom AAC Devices Market, By Device Type, 2023-2029 (USD Million)
Table A28: United Kingdom AAC Devices Market, By Application, 2019-2022 (USD Million)
Table A29: United Kingdom AAC Devices Market, By Application, 2023-2029 (USD Million)
Table A30: United Kingdom AAC Devices Market, By End-Users, 2019-2022 (USD Million)
Table A31: United Kingdom AAC Devices Market, By End-Users, 2023-2029 (USD Million)
Table A32: France AAC Devices Market, By Device Type, 2019-2022 (USD Million)
Table A33: France AAC Devices Market, By Device Type, 2023-2029 (USD Million)
Table A34: France AAC Devices Market, By Application, 2019-2022 (USD Million)
Table A35: France AAC Devices Market, By Application, 2023-2029 (USD Million)
Table A36: France AAC Devices Market, By End-Users, 2019-2022 (USD Million)
Table A37: France AAC Devices Market, By End-Users, 2023-2029 (USD Million)
Table A38: Norway AAC Devices Market, By Device Type, 2019-2022 (USD Million)
Table A39: Norway AAC Devices Market, By Device Type, 2023-2029 (USD Million)
Table A40: Norway AAC Devices Market, By Application, 2019-2022 (USD Million)
Table A41: Norway AAC Devices Market, By Application, 2023-2029 (USD Million)
Table A42: Norway AAC Devices Market, By End-Users, 2019-2022 (USD Million)
Table A43: Norway AAC Devices Market, By End-Users, 2023-2029 (USD Million)
Table A44: China AAC Devices Market, By Device Type, 2019-2022 (USD Million)
Table A45: China AAC Devices Market, By Device Type, 2023-2029 (USD Million)
Table A46: China AAC Devices Market, By Application, 2019-2022 (USD Million)
Table A47: China AAC Devices Market, By Application, 2023-2029 (USD Million)
Table A48: China AAC Devices Market, By End-Users, 2019-2022 (USD Million)
Table A49: China AAC Devices Market, By End-Users, 2023-2029 (USD Million)
Table A50: Japan AAC Devices Market, By Device Type, 2019-2022 (USD Million)
Table A51: Japan AAC Devices Market, By Device Type, 2023-2029 (USD Million)
Table A52: Japan AAC Devices Market, By Application, 2019-2022 (USD Million)
Table A53: Japan AAC Devices Market, By Application, 2023-2029 (USD Million)
Table A54: Japan AAC Devices Market, By End-Users, 2019-2022 (USD Million)
Table A55: Japan AAC Devices Market, By End-Users, 2023-2029 (USD Million)
Table A56: Australia AAC Devices Market, By Device Type, 2019-2022 (USD Million)
Table A57: Australia AAC Devices Market, By Device Type, 2023-2029 (USD Million)
Table A58: Australia AAC Devices Market, By Application, 2019-2022 (USD Million)
Table A59: Australia AAC Devices Market, By Application, 2023-2029 (USD Million)
Table A60: Australia AAC Devices Market, By End-Users, 2019-2022 (USD Million)
Table A61: Australia AAC Devices Market, By End-Users, 2023-2029 (USD Million)
Table A62: Middle East & Africa AAC Devices Market, By Device Type, 2019-2022 (USD Million)
Table A63: Middle East & Africa AAC Devices Market, By Device Type, 2023-2029 (USD Million)
Table A64: Middle East & Africa AAC Devices Market, By Application, 2019-2022 (USD Million)
Table A65: Middle East & Africa AAC Devices Market, By Application, 2023-2029 (USD Million)
Table A66: Middle East & Africa AAC Devices Market, By End-Users, 2019-2022 (USD Million)
Table A67: Middle East & Africa AAC Devices Market, By End-Users, 2023-2029 (USD Million)
Table A68: Tobii Dynavox Key Financials, 2020-2022